{"id":"https://openalex.org/W2323405385","doi":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","title":"Evaluation of PolyMPC\u2013Dox Prodrugs in a Human Ovarian Tumor Model","display_name":"Evaluation of PolyMPC\u2013Dox Prodrugs in a Human Ovarian Tumor Model","publication_year":2016,"publication_date":"2016-03-29","ids":{"openalex":"https://openalex.org/W2323405385","doi":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","mag":"2323405385","pmid":"https://pubmed.ncbi.nlm.nih.gov/27023764"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.6b00092","doi":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089924473","display_name":"Kaitlyn E. Wong","orcid":"https://orcid.org/0000-0001-5179-3643","observed_orcids":["https://orcid.org/0000-0001-5179-3643"]},"institutions":[{"id":"https://openalex.org/I1338449461","display_name":"Baystate Medical Center","ror":"https://ror.org/01q2nz307","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1338449461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn E. Wong","raw_affiliation_strings":["Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","institution_ids":["https://openalex.org/I1338449461"]},{"raw_affiliation_string":"Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050554057","display_name":"Maria Carmen Mora","orcid":"https://orcid.org/0000-0002-1961-7882","observed_orcids":["https://orcid.org/0000-0002-1961-7882"]},"institutions":[{"id":"https://openalex.org/I1338449461","display_name":"Baystate Medical Center","ror":"https://ror.org/01q2nz307","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1338449461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria C. Mora","raw_affiliation_strings":["Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","institution_ids":["https://openalex.org/I1338449461"]},{"raw_affiliation_string":"Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Skinner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24603500","display_name":"University of Massachusetts Amherst","ror":"https://ror.org/0072zz521","country_code":"US","type":"education","lineage":["https://openalex.org/I24603500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Skinner","raw_affiliation_strings":["Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States","institution_ids":["https://openalex.org/I24603500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088365235","display_name":"Samantha McRae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24603500","display_name":"University of Massachusetts Amherst","ror":"https://ror.org/0072zz521","country_code":"US","type":"education","lineage":["https://openalex.org/I24603500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha McRae Page","raw_affiliation_strings":["Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States","institution_ids":["https://openalex.org/I24603500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014419275","display_name":"Giovanna Maria Crisi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1338449461","display_name":"Baystate Medical Center","ror":"https://ror.org/01q2nz307","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1338449461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanna M. Crisi","raw_affiliation_strings":["Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","institution_ids":["https://openalex.org/I1338449461"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104363739","display_name":"Richard B. Arenas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1338449461","display_name":"Baystate Medical Center","ror":"https://ror.org/01q2nz307","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1338449461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Arenas","raw_affiliation_strings":["Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baystate Medical Center, 759 Chestnut\rStreet, Springfield, Massachusetts 01199, United States","institution_ids":["https://openalex.org/I1338449461"]},{"raw_affiliation_string":"Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012333995","display_name":"Sallie S. Schneider","orcid":"https://orcid.org/0000-0003-0093-4308","observed_orcids":["https://orcid.org/0000-0003-0093-4308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sallie S. Schneider","raw_affiliation_strings":["Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pioneer Valley Life Sciences Institute, 3601 Main Street, Springfield, Massachusetts 01199, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030195131","display_name":"Todd S. Emrick","orcid":"https://orcid.org/0000-0003-0460-1797","observed_orcids":["https://orcid.org/0000-0003-0460-1797"]},"institutions":[{"id":"https://openalex.org/I24603500","display_name":"University of Massachusetts Amherst","ror":"https://ror.org/0072zz521","country_code":"US","type":"education","lineage":["https://openalex.org/I24603500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Todd Emrick","raw_affiliation_strings":["Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polymer Science & Engineering Department, University of Massachusetts, 120 Governors Drive, Amherst, Massachusetts 01003, United States","institution_ids":["https://openalex.org/I24603500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030195131"],"corresponding_institution_ids":["https://openalex.org/I24603500"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.816,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.65971302,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"13","issue":"5","first_page":"1679","last_page":"1687"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11686","display_name":"Dendrimers and Hyperbranched Polymers","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polymer-prodrugs","display_name":"polymer prodrugs","score":0.7879999876022339},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ovarian-neoplasms","display_name":"ovarian neoplasms","score":0.8180000185966492},{"id":"https://openalex.org/keywords/skov-3-cells","display_name":"SKOV3 cells","score":0.8550000190734863},{"id":"https://openalex.org/keywords/enhanced-permeability-and-retention-effect","display_name":"enhanced permeability and retention effect","score":0.7680000066757202},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.531000018119812},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.5389999747276306},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.5960000157356262},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6840000152587891},{"id":"https://openalex.org/keywords/biocompatibility","display_name":"biocompatibility","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.8139762878417969},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5282391905784607},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4465640187263489},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4230967164039612},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41753190755844116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.347539484500885},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32675108313560486},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3101964592933655},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23209184408187866},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16292542219161987}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010767","descriptor_name":"Phosphorylcholine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.6b00092","doi":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.6b00092","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:27023764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27023764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1432574109","display_name":"A Phosphorylcholine Vesicle (PCV) Platform for Cancer Therapeutics","funder_award_id":"R21CA167674","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337367","display_name":"Division of Materials Research","ror":"https://ror.org/01pc7k308"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1668529463","https://openalex.org/W1759932079","https://openalex.org/W1871308790","https://openalex.org/W1919306097","https://openalex.org/W1978654303","https://openalex.org/W1987593270","https://openalex.org/W2002516695","https://openalex.org/W2003977399","https://openalex.org/W2019342785","https://openalex.org/W2024714448","https://openalex.org/W2041647205","https://openalex.org/W2072198924","https://openalex.org/W2080774121","https://openalex.org/W2084308282","https://openalex.org/W2084535944","https://openalex.org/W2088659772","https://openalex.org/W2090453278","https://openalex.org/W2090578536","https://openalex.org/W2091446581","https://openalex.org/W2093480017","https://openalex.org/W2108165319","https://openalex.org/W2121354326","https://openalex.org/W2148030770","https://openalex.org/W2148759318","https://openalex.org/W2168943084","https://openalex.org/W2174160083","https://openalex.org/W2177410322","https://openalex.org/W2184694295","https://openalex.org/W2315090335"],"related_works":["https://openalex.org/W7096127544","https://openalex.org/W201068546","https://openalex.org/W2093480017","https://openalex.org/W2092639730","https://openalex.org/W1996795772","https://openalex.org/W4250740407","https://openalex.org/W132909248","https://openalex.org/W2085129137","https://openalex.org/W2157166246","https://openalex.org/W2021700423"],"abstract_inverted_index":{"A":[0],"polymer":[1,69],"prodrug,":[2],"composed":[3],"of":[4,18,45,67,88,98,123,134,186,199,217],"doxorubicin":[5],"(Dox)":[6],"conjugated":[7],"covalently":[8],"to":[9,32,61,145,154,165,175,205],"poly(methacryloyloxyethyl":[10],"phosphorylcholine)":[11],"(polyMPC),":[12],"was":[13,54,79],"evaluated":[14],"for":[15],"the":[16,65,68,76,94,104,121,139],"treatment":[17,176],"human":[19,110,155,219],"ovarian":[20,111,156,220],"tumors":[21,118,221],"in":[22,36,56,81,103,117,212,231],"animals.":[23],"PolyMPC-Dox":[24],"prodrugs":[25],"were":[26],"prepared":[27],"using":[28,159],"facile":[29],"conjugation":[30],"chemistry":[31],"yield":[33],"conjugates":[34],"soluble":[35],"water":[37],"and":[38,141,149,233],"injectable":[39],"saline,":[40],"with":[41,126,177,183,194,208,222],"a":[42,72,84,109,132,160,195],"Dox":[43,85,100],"loading":[44],"\u223c19":[46],"weight":[47],"percent.":[48],"Toxicity":[49],"evaluation":[50],"showed":[51],"that":[52,166],"polyMPC":[53],"well-tolerated":[55,80],"mice":[57,158,206],"at":[58,71,83,119],"doses":[59,185],"up":[60],"800":[62],"mg/kg,":[63,90],"confirming":[64],"biocompatibility":[66],"carrier":[70],"high":[73],"concentration.":[74],"Additionally,":[75],"polyMPC-Dox":[77,115,169,187],"prodrug":[78,140],"animals":[82,181],"equivalent":[86],"dose":[87,97],"10":[89],"greater":[91],"than":[92],"twice":[93,120],"maximum":[95],"tolerated":[96],"free":[99,124,178,209],"(\u223c4":[101],"mg/kg)":[102],"same":[105],"mouse":[106],"strain.":[107],"In":[108],"tumor":[112,172],"model":[113],"(SKOV-3),":[114],"accumulated":[116],"level":[122],"Dox,":[125],"no":[127],"additional":[128],"off-target":[129],"organ":[130],"uptake,":[131],"result":[133],"improved":[135,228],"pharmacokinetics":[136],"afforded":[137],"by":[138],"passive":[142],"targeting":[143],"attributed":[144],"an":[146],"enhanced":[147,192,234],"permeability":[148],"retention":[150],"effect.":[151],"When":[152],"administered":[153],"tumor-bearing":[157],"recurring":[161],"dosing":[162],"regimen":[163],"comparable":[164],"used":[167],"clinically,":[168],"significantly":[170],"retarded":[171],"growth":[173],"relative":[174,204],"Dox.":[179,210],"Moreover,":[180],"treated":[182,207],"multiple":[184],"(eight":[188],"total":[189],"doses)":[190],"exhibited":[191],"survival,":[193],"notably":[196],"reduced":[197,225],"incidence":[198],"toxicity":[200],"or":[201],"adverse":[202],"events":[203],"These":[211],"vivo":[213],"results":[214],"demonstrate":[215],"advantages":[216],"treating":[218],"polyMPC-Dox,":[223],"including":[224],"systemic":[226],"toxicity,":[227],"drug":[229],"accumulation":[230],"tumors,":[232],"therapeutic":[235],"efficacy.":[236]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}